ZIPtide
|
ZIPTIDE
|
|
α-Casein (90-96)
|
Α-CASEIN (90-96)
|
|
α-Neoendorphin (1-8)
|
TYR-GLY-GLY-PHE-LEU-ARG-LYS-TYR
|
83339-89-3
|
β-catenin peptide
|
265669-37-2
|
265669-37-2
|
β-Pompilidotoxin TFA
|
Β-POMPILIDOTOXIN TFA
|
|
osteogenic growth polypeptide
|
成骨生長(zhǎng)多肽
|
|
Protease-Activated Receptor-2, amide
|
蛋白酶活化的受體-2,酰胺
|
|
ASP-LEU-ASP-VAL-PRO-ILE-PRO-GLY-ARG-PHE-ASP-ARG-ARG-VAL-SER-VAL-ALA-ALA-GLU
|
鈣調(diào)神經(jīng)磷酸酶底物
|
113873-67-9
|
MYOMODULIN
|
肌調(diào)蛋白
|
110570-93-9
|
KKI 5
|
激肽釋放酶抑制劑
|
97145-43-2
|
Melanotan-1
|
美拉諾坦
|
75921-69-6
|
Thymopentin
|
胸腺五肽
|
69558-55-0
|
DSIP
|
依米地肽
|
62568-57-4
|
TUFTSIN ACETATE SALT
|
增免疫蘇精肽
|
72103-53-8
|
(Cys8·13)-Dynorphin A (1-13) amide
|
TYR-GLY-GLY-PHE-LEU-ARG-ARG-CYS-ARG-PRO-LYS-LEU-CYS-NH2 (DISULFIDE BRIDGE:CYS8-CYS13)
|
|
Dynorphin A (1-11) amide
|
DYNORPHIN A (1-11) AMIDE
|
79985-48-1
|
Dynorphin A (1-13), amide, porcine
|
TYR-GLY-GLY-PHE-LEU-ARG-ARG-ILE-ARG-PRO-LYS-LEU-LYS-NH2
|
79515-34-7
|
Dynorphin A (1-9)
|
DYNORPHIN A (1-9)
|
77259-54-2
|
Dynorphin A(1-7)
|
DYNORPHIN A (1-7)
|
77101-32-7
|
Dynorphin B (1-9)
|
TYR-GLY-GLY-PHE-LEU-ARG-ARG-GLN-PHE
|
126050-26-8
|
DynorphinA(1-8)
|
DYNORPHIN A (1-8)
|
75790-53-3
|
Dynorphin A
|
強(qiáng)啡肽A
|
|
DYNORPHIN B
|
豬強(qiáng)啡肽 B
|
83335-41-5
|
Hemokinin 1 (mouse, rat)
|
ARG-SER-ARG-THR-ARG-GLN-PHE-TYR-GLY-LEU-MET-NH2
|
208041-90-1
|
Hemokinin1(human)
|
HEMOKININ 1 (HUMAN)
|
491851-53-7
|
(His32,Leu34)-Neuropeptide Y (32-36)
|
(HIS32,LEU34)-NEUROPEPTIDE Y (32-36)
|
168916-68-5
|
(Lys8,Lys9)-Neurotensin (8-13)
|
神經(jīng)降壓素(Lys8,Lys9)-Neurotensin (8-13)
|
139026-64-5
|
(Pro30,Tyr32,Leu34)-Neuropeptide Y (28-36)
|
(PRO30,TYR32,LEU34)-NEUROPEPTIDE Y (28-36)
|
161650-01-7
|
(Pro7)-NKB
|
(PRO7)-NKB
|
|
(Trp11)-Neurotensin
|
(TRP11)-NEUROTENSIN
|
|
Gln4]Neurotensin
|
(GLN4)-NEUROTENSIN
|
|
Lys8,Asn9]-Neurotensin (8-13)
|
LYS-ASN-PRO-TYR-ILE-LEU
|
|
Ser2]-Neuromedin C
|
GLY-SER-HIS-TRP-ALA-VAL-GLY-HIS-LEU-MET-NH2
|
136058-54-3
|
VKKR
|
VKKR
|
|
VLSEG
|
VLSEG
|
|
WGGY
|
WGGY
|
|
Xenopsin
|
非洲爪蟾肽
|
51827-01-1
|
Syk Kinase Peptide Substrate
|
SYK KINASE PEPTIDE SUBSTRATE
|
|
TLQP-21 (human)
|
TLQP-21
|
1259837-37-0
|
TCS 184
|
TCS 183對(duì)照肽
|
1315378-71-2
|
TCTDSTNCYKAT
|
TCTDSTNCYKAT
|
1621188-94-0
|
Tetanus toxin (830-843)
|
Tetanus toxin (830-843)
|
119260-99-0
|
Tetanus Toxin (830-844)
|
TETANUS TOXIN (830-844)
|
|
Thioredoxin reductase peptide TFA
|
Thioredoxin reductase peptide (TFA)
|
|
TNF-α (31-45)
|
TNF-Α (31-45)
|
|
TNF-α (46-65)
|
TNF-Α (46-65)
|
|
TRAP-14 amide
|
SER-PHE-LEU-LEU-ARG-ASN-PRO-ASN-ASP-LYS-TYR-GLU-PRO-PHE-NH2
|
141923-36-6
|
TRV056
|
血管緊張素配體多肽TRV056
|
812644-79-4
|
TRV120056
|
激動(dòng)劑多肽TRV120056
|
40678-47-5
|
Tryptophan Motif Peptide
|
GLY-GLY-TRP-SER-HIS-TRP-NH2
|
|
TSST-1 (58-78)
|
TOXIC SHOCK SYNDROME TOXIN-1 (TSST-1) (58-78)
|
|
Tyrosine Kinase Peptide 1
|
TYROSINE KINASE PEPTIDE 1
|
|
Tyrosine Kinase Peptide 3 [RRLIEDAEYAARG], Phosphorylated
|
TYROSINE KINASE PEPTIDE 3 [RRLIEDAEYAARG], PHOSPHORYLATED
|
|
Uty HY Peptide (246-254)
|
Uty HY Peptide (246-254)
|
261172-28-5
|
VEGFR2/KDR Antagonist
|
ATWLPPR
|
|
Vitronectin (367-378)
|
VITRONECTIN (367-378)
|
|
S3 Fragment, ADF/cofilin
|
S3 FRAGMENT, ADF/COFILIN
|
|
Saposin C22
|
CYS-GLU-PHE-LEU-VAL-LYS-GLU-VAL-THR-LYS-LEU-ILE-ASP-ASN-ASN-LYS-THR-GLU-LYS-GLU-ILE-LEU
|
|
Sc-4F
|
SC-4F
|
|
SCpanx, Pannexin 1, Scrambled
|
SCPANX, PANNEXIN 1, SCRAMBLED
|
|
Scrambled TRAP Fragment
|
PHE-SER-LEU-LEU-ARG-ASN-NH2
|
|
SH2 Domain Ligand (1)
|
AC-ASP-TYR(PO3H2)-VAL-PRO-MET-LEU-NH2
|
157382-69-9
|
Shepherdin (79-87)
|
SHEPHERDIN (79-87)
|
|
H-SER-LEU-LEU-LYS-NH2
|
SLLK,TSP1抑制劑控制肽
|
464924-27-4
|
SLSLSPG
|
SLSLSPG
|
|
Smcy HY Peptide (738-746)
|
Smcy HY Peptide
|
207113-06-2
|
Sodefrin
|
SER-ILE-PRO-SER-LYS-ASP-ALA-LEU-LEU-LYS
|
|
Spadin TFA
|
SPADIN TFA
|
|
MOG (40-54)
|
MOG (40-54)
|
|
MOG (45-54)
|
MOG (45-54)
|
|
MOG (8-21)
|
MOG (8-21)
|
|
MOG (91-108), rat
|
MOG (91-108), RAT
|
|
MOG (92-106)
|
MOG (92-106)
|
|
Myelin Oligodendrocyte Basic Protein (16-37)
|
MYELIN OLIGODENDROCYTE BASIC PROTEIN (16-37)
|
|
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), (mouse,rat)
|
髓鞘少突膠質(zhì)細(xì)胞糖蛋白
|
149635-73-4
|
Neuro Peptide S, rat
|
NEUROPEPTIDE S (RAT)
|
412938-75-1
|
Neuro Peptide Y(18-36), porcine
|
TYR-PRO-SER-LYS-PRO-ASP-ASN-PRO-GLY-GLU-ASP-ALA-PRO-ALA-GLU-ASP-MET-ALA-ARG-TYR-TYR-SER-ALA-LEU-ARG-HIS-TYR-ILE-ASN-LEU-ILE-THR-ARG-GLN-ARG-TYR: YPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY
|
98264-90-5
|
Trp11]-Neurotensin (8-13)
|
ARG-ARG-PRO-TRP-ILE-LEU
|
|
Tyr0]-Neurokinin B
|
TYR-ASP-MET-HIS-ASP-PHE-PHE-VAL-GLY-LEU-MET-NH2: YDMHDFFVGLM-NH2
|
|
Tyr0]NeurokininA
|
(TYR0)-NEUROKININ A
|
116868-93-0
|
Acetyl-Neurotensin (8-13)
|
Acetyl neurotensin (8-13)
|
74853-69-3
|
Ac-RYYRWK-NH2
|
AC-ARG-TYR-TYR-ARG-TRP-LYS-NH2
|
200959-47-3
|
Activity-Dependent Neurotrophic Factor, ADNF
|
SER-ALA-LEU-LEU-ARG-SER-ILE-PRO-ALA
|
|
Biotin-Dynorphin A (1-17)
|
BIOTIN-TYR-GLY-GLY-PHE-LEU-ARG-ARG-ILE-ARG-PRO-LYS-LEU-LYS-TRP-ASP-ASN-GLN
|
|
Biotin-Neurokinin A
|
BIOTIN -HIS-LYS-THR-ASP-SER-PHE-VAL-GLY-LEU-MET-NH2
|
|
Brain Neuropeptide II
|
BRAIN NEUROPEPTIDE II
|
|
Buccalin
|
GLY-MET-ASP-SER-LEU-ALA-PHE-SER-GLY-GLY-LEU-NH2
|
116844-51-0
|
Catestatin, Chromogranin A (352-372), human
|
CATESTATIN, CHROMOGRANIN A (352-372), HUMAN
|
|
Cerebellin
|
SER-GLY-SER-ALA-LYS-VAL-ALA-PHE-SER-ALA-ILE-ARG-SER-THR-ASN-HIS: SGSAKVAFSAIRSTNH
|
94071-26-8
|
Dynorphin A (1-10)
|
DYNORPHIN A (1-10)
|
79994-24-4
|
Dynorphin A (2-13), porcine
|
GLY-GLY-PHE-LEU-ARG-ARG-ILE-ARG-PRO-LYS-LEU-LYS
|
|
Eledoisin Related Peptide
|
LYS-PHE-ILE-GLY-LEU-MET-NH2
|
2990-43-4
|
FMRF-NH2
|
PHE-MET-ARG-PHE-NH2
|
152165-14-5
|
GAD65 (206-220)
|
THR-TYR-GLU-ILE-ALA-PRO-VAL-PHE-VAL-LEU-LEU-GLU-TYR-VAL-THR
|
|
Galanin Like Peptide, GALP (41-60), human, porcine, rat
|
GALANIN LIKE PEPTIDE, GALP (41-60), HUMAN, PORCINE, RAT
|
|
Glutamate Receptor Endocytosis Inhibitor, GluR23Y
|
Glutamate Receptor Endocytosis Inhibitor, GluR23Y
|
|
Head Activator Neuropeptide
|
GLP-PRO-PRO-GLY-GLY-SER-LYS-VAL-ILE-LEU-PHE
|
|
LCMV GP61
|
LCMV GP61
|
|
MOG (35-52)
|
MOG (35-52)
|
|
MOG (35-55),human
|
MYELIN OLIGODENDROCYTE GLYCOPROTEIN (35-55) (HUMAN)
|
163158-19-8
|